Cargando…

In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q

Filarial parasites modulate effective immune response of their host by releasing a variety of immunomodulatory molecules, which help in the long persistence of the parasite within the host. The present study was aimed to characterize an immunomodulatory protein of Brugia malayi and its interaction w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Sunita, Gupta, Smita, Selvaraj, Chandrabose, Doharey, Pawan Kumar, Verma, Anita, Singh, Sanjeev Kumar, Saxena, Jitendra Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153637/
https://www.ncbi.nlm.nih.gov/pubmed/25184227
http://dx.doi.org/10.1371/journal.pone.0106413
_version_ 1782333315138715648
author Yadav, Sunita
Gupta, Smita
Selvaraj, Chandrabose
Doharey, Pawan Kumar
Verma, Anita
Singh, Sanjeev Kumar
Saxena, Jitendra Kumar
author_facet Yadav, Sunita
Gupta, Smita
Selvaraj, Chandrabose
Doharey, Pawan Kumar
Verma, Anita
Singh, Sanjeev Kumar
Saxena, Jitendra Kumar
author_sort Yadav, Sunita
collection PubMed
description Filarial parasites modulate effective immune response of their host by releasing a variety of immunomodulatory molecules, which help in the long persistence of the parasite within the host. The present study was aimed to characterize an immunomodulatory protein of Brugia malayi and its interaction with the host immune component at the structural and functional level. Our findings showed that Brugia malayi Calreticulin (BmCRT) is responsible for the prevention of classical complement pathway activation via its interaction with the first component C1q of the human host. This was confirmed by inhibition of C1q dependent lysis of immunoglobulin-sensitized Red Blood Cells (S-RBCs). This is possibly the first report which predicts CRT-C1q interaction on the structural content of proteins to explain how BmCRT inhibits this pathway. The molecular docking of BmCRT-C1q complex indicated that C1qB chain (IgG/M and CRP binding sites on C1q) played a major role in the interaction with conserved and non-conserved regions of N and P domain of BmCRT. Out of 37 amino acids of BmCRT involved in the interaction, nine amino acids (Pro(126), Glu(132), His(147), Arg(151), His(153), Met(154), Lys(156), Ala(196) and Lys(212)) are absent in human CRT. Both ELISA and in silico analysis showed the significant role of Ca(+2) in BmCRT-HuC1q complex formation and deactivation of C1r(2)–C1s(2). Molecular dynamics studies of BmCRT-HuC1q complex showed a deviation from ∼0.4 nm to ∼1.0 nm. CD analyses indicated that BmCRT is composed of 49.6% α helix, 9.6% β sheet and 43.6% random coil. These findings provided valuable information on the architecture and chemistry of BmCRT-C1q interaction and supported the hypothesis that BmCRT binds with huC1q at their targets (IgG/M, CRP) binding sites. This interaction enables the parasite to interfere with the initial stage of host complement activation, which might be helpful in parasites establishment. These results might be utilized for help in blocking the C1q/CRT interaction and preventing parasite infection.
format Online
Article
Text
id pubmed-4153637
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41536372014-09-05 In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q Yadav, Sunita Gupta, Smita Selvaraj, Chandrabose Doharey, Pawan Kumar Verma, Anita Singh, Sanjeev Kumar Saxena, Jitendra Kumar PLoS One Research Article Filarial parasites modulate effective immune response of their host by releasing a variety of immunomodulatory molecules, which help in the long persistence of the parasite within the host. The present study was aimed to characterize an immunomodulatory protein of Brugia malayi and its interaction with the host immune component at the structural and functional level. Our findings showed that Brugia malayi Calreticulin (BmCRT) is responsible for the prevention of classical complement pathway activation via its interaction with the first component C1q of the human host. This was confirmed by inhibition of C1q dependent lysis of immunoglobulin-sensitized Red Blood Cells (S-RBCs). This is possibly the first report which predicts CRT-C1q interaction on the structural content of proteins to explain how BmCRT inhibits this pathway. The molecular docking of BmCRT-C1q complex indicated that C1qB chain (IgG/M and CRP binding sites on C1q) played a major role in the interaction with conserved and non-conserved regions of N and P domain of BmCRT. Out of 37 amino acids of BmCRT involved in the interaction, nine amino acids (Pro(126), Glu(132), His(147), Arg(151), His(153), Met(154), Lys(156), Ala(196) and Lys(212)) are absent in human CRT. Both ELISA and in silico analysis showed the significant role of Ca(+2) in BmCRT-HuC1q complex formation and deactivation of C1r(2)–C1s(2). Molecular dynamics studies of BmCRT-HuC1q complex showed a deviation from ∼0.4 nm to ∼1.0 nm. CD analyses indicated that BmCRT is composed of 49.6% α helix, 9.6% β sheet and 43.6% random coil. These findings provided valuable information on the architecture and chemistry of BmCRT-C1q interaction and supported the hypothesis that BmCRT binds with huC1q at their targets (IgG/M, CRP) binding sites. This interaction enables the parasite to interfere with the initial stage of host complement activation, which might be helpful in parasites establishment. These results might be utilized for help in blocking the C1q/CRT interaction and preventing parasite infection. Public Library of Science 2014-09-03 /pmc/articles/PMC4153637/ /pubmed/25184227 http://dx.doi.org/10.1371/journal.pone.0106413 Text en © 2014 Yadav et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yadav, Sunita
Gupta, Smita
Selvaraj, Chandrabose
Doharey, Pawan Kumar
Verma, Anita
Singh, Sanjeev Kumar
Saxena, Jitendra Kumar
In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
title In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
title_full In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
title_fullStr In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
title_full_unstemmed In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
title_short In Silico and In Vitro Studies on the Protein-Protein Interactions between Brugia malayi Immunomodulatory Protein Calreticulin and Human C1q
title_sort in silico and in vitro studies on the protein-protein interactions between brugia malayi immunomodulatory protein calreticulin and human c1q
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153637/
https://www.ncbi.nlm.nih.gov/pubmed/25184227
http://dx.doi.org/10.1371/journal.pone.0106413
work_keys_str_mv AT yadavsunita insilicoandinvitrostudiesontheproteinproteininteractionsbetweenbrugiamalayiimmunomodulatoryproteincalreticulinandhumanc1q
AT guptasmita insilicoandinvitrostudiesontheproteinproteininteractionsbetweenbrugiamalayiimmunomodulatoryproteincalreticulinandhumanc1q
AT selvarajchandrabose insilicoandinvitrostudiesontheproteinproteininteractionsbetweenbrugiamalayiimmunomodulatoryproteincalreticulinandhumanc1q
AT dohareypawankumar insilicoandinvitrostudiesontheproteinproteininteractionsbetweenbrugiamalayiimmunomodulatoryproteincalreticulinandhumanc1q
AT vermaanita insilicoandinvitrostudiesontheproteinproteininteractionsbetweenbrugiamalayiimmunomodulatoryproteincalreticulinandhumanc1q
AT singhsanjeevkumar insilicoandinvitrostudiesontheproteinproteininteractionsbetweenbrugiamalayiimmunomodulatoryproteincalreticulinandhumanc1q
AT saxenajitendrakumar insilicoandinvitrostudiesontheproteinproteininteractionsbetweenbrugiamalayiimmunomodulatoryproteincalreticulinandhumanc1q